The Treatment Information Group is a public interest initiative to promote research-based debate of antiretroviral drug policy, alternative non-toxic treatment approaches to AIDS, and HIV testing issues in South Africa. The TIG was founded by Adv Anthony Brink (PDF, 23kB).

Click here to send us an email.

Phone:
+27 (0) 21 4264513
 
Fax:
+27 (0) 86 6720776

Write:
Postnet Suite 273
Private Bag X1
Vlaeberg 8018
Cape Town
South Africa

» Why do President Mbeki and
Dr Tshabalala-Msimang
warn against the use of
ARV drugs like AZT?
(PDF, 98 kB)
 
» Warum warnen der südafri-
kanische Präsident Thabo
Mbeki und Gesundheits-
ministerin Dr. Manto
Tshabalala-Msimang vor
dem Gebrauch von Anti-
retroviralen Medika-
menten wie AZT?
(PDF, 698 kB)
 
» Why do Zackie Achmat,
Nathan Geffen and Mark
Heywood want pregnant
African women to be
given AZT? What AZT
does to unborn babies.
(PDF, 76 kB)
 
» Warum wollen Zackie
Achmat, Nathan Geffen
und Mark Heywood
schwangeren afrikanischen
Frauen und deren Babies
AZT verabreichen?
(PDF, 77 kB)
 
» AZT flyer – isiXhosa
(PDF, 203 kB)
 
» AZT flyer – isiZulu
(PDF, 188 kB)
 
» Debating AZT: Mbeki and
the AIDS drug controversy
(PDF, 1.19 MB)

» Introducing AZT: 'A world
of antiretroviral experience'
(PDF, 445 kB)

» Inventing AZT
(PDF, 28 kB)

» Licensing AZT
(PDF, 40 kB)

» Poisoning our Children:
AZT in pregnancy
(PDF, 551 kB)

» An Open Letter to Glaxo
SmithKline CEO John Kearny
(PDF, 51 kB)

» The trouble with nevirapine
(PDF, 842 kB)

» A Critical Analysis of the
Pharmacology of AZT and
its use in AIDS
(PDF, 416 kB)

» Mother to Child Transmission
of HIV and its Prevention
with AZT and Nevirapine
(PDF, 2.03 MB)

» A Critical Analysis of the
Evidence Considered Proof
that Nevirapine Prevents
Mother-to-Child Trans-
mission of HIV
(PDF, 1.18 MB)